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• Abstract 
Alterations of Ca2+ signaling have been linked to several genetic neuromuscular 
diseases, thus it is important to uncover the toolkit components and intracellular 
pathways involved in Ca2+ signaling under normal and pathological conditions. 
  
Calcium homeostasis in striated muscles 
Over the decades, the role(s) played by Ca2+ in skeletal muscle have been 
unveiled and it is now clearly established that it is the key molecule underlying muscle 
contraction. Its importance is given by the fact that movement of the contractile proteins 
is dependent on the Ca2+ released from the sarcoplasmic reticulum (SR), an organelle 
constituting approximately 10% of the cell’s volume and fully dedicated to uptake and 
release of Ca2+ (Peachey, 1965; Volpe, 1991). The SR can be structurally divided into 
two distinct portions: the terminal cisternae, which face the transverse tubules (an 
invagination of the plasma membrane) and the longitudinal sarcoplasmic reticulum, 
connecting two terminal cisternae. The terminal cisternae can be further divided into 
junctional face membrane (the domain facing the transverse tubules) and non junctional 
membrane (Saito, 1984; Costello, 1986).  
Depolarization of the plasma membrane of skeletal muscle leads to release of 
Ca2+ from the SR resulting in muscle contraction, by a process known as excitation-
contraction coupling (Schneider, 1972; Melzer, 1995; Berchtold, 2000). Excitation-
contraction coupling (EC coupling) occurs at the triad, a structure composed of the two 
membrane compartments, transverse tubules containing the voltage sensing 
dihydropyridine receptor (DHPR, an L-type Ca2+ channel) and terminal cisternae on 
which ryanodine receptor (RyR) Ca2+ release channels are localized (Mitchell, 1983; Rios 
1991). The disposition of DHPRs and RyRs on their respective membranes is highly 
ordered and each RyR tetramer faces alternative rows of DHPRs (figure 1) (Block, 1988; 
Franzini-Armstrong, 1994; Paolini, 2004). These two Ca2+ channels are the basic unit 
underlying excitation-contraction coupling but they do not function alone, but rather can 
be thought of as macromolecular structures, composed of a number of accessory proteins 
involved in their fine regulation. 
 
Major and minor protein components of the sarcoplasmic reticulum 
One of the major advances in the field of excitation-contraction coupling was the 
development of reproducible procedures enabling the fractionation of SR membranes 
enriched in proteins involved in calcium handling (Campbell, 1980; Meissner, 1973; 
Saito, 1984). This revealed that protein components of the longitudinal SR (LSR) and 
terminal cisternae are different, reflecting the functional subspecialization of these 
membrane fractions, which are respectively, Ca2+ uptake and Ca2+ release. Figure 2 
shows a 5-15% SDS PAG stained with Coomassie Brilliant Blue of the protein 
components of LSR, terminal cisternae and junctional face membrane. The major 
component of the LSR constituting approximately 80% of the total proteins present, is the 
110 kDa CaATPase (SERCA), i.e. the pump responsible for pumping the Ca2+ released 
by the RyR1s back into the SR. The 22kDa protein band present in the longitudinal SR 
fraction is phospholamban, a protein involved in regulating the activity of the SERCA 
pump in heart and slow twitch muscle fibers. When phospholamban is de-
phosphorylated, it inhibits the activity of SERCA, whereas in its phosphorylated state, 
inhibition is relieved (Slack, 1997; Liu, 1997; MacLennan, 2003). Ablation of 
phospholamban causes a significant (25%) decrease in the time to half relaxation of 
isolated solei with no change in the contraction time (Jay, 1997), supporting its important 
role in regulating of SERCA activity. 
Two glycoproteins of 160 kDa (sarcalumenin) and 53 kDa (53 kDa glycoprotein) 
represent minor protein constituents of the LSR membrane fraction and are generated by 
alternative splicing of the same transcript, which is expressed both in heart and skeletal 
muscle. The large transcript (sarcalumenin) is a low affinity (kD= 0.6 mM) high capacity 
(35 mol/mol protein) Ca2+ binding protein, while the shorter product of 53 kDa, lacks the 
NH2 and thus the Ca2+ binding domain. Sarcalumenin is involved in the maintenance of 
the SERCA protein as illustrated by the fact that sarcalumenin KO animals exhibit 
significant decreased SERCA activity and SERCA protein content (Leberer, 1990; 
Yoshida, 2005).  
As shown in figure 2, the protein composition of the JFM is far more complex 
than that of the LSR (Costello, 1986); aside the most abundant components, including the 
ryanodine receptor (RyR), calsequestrin (CsQ), histidine rich Ca2+ binding protein and 
traidin(s) (TRISK) which will not be discussed in this review, there are a number of other 
minor protein components whose function has recently been unraveled or that still await 
functional characterization. Much work has focused on the identification of the full set of 
protein constituents of the junctional face membrane (JFM) and on understanding their 
functional role in excitation-contraction coupling. Two main approaches have been used 
to characterize the minor membrane-protein components at the molecular, cellular and 
functional level: (i) the immuno-proteomic approach utilized by Takeshima’s lab, which 
combines production of monoclonal Abs against membrane proteins selected on the base 
of specific triadic immunostaining of muscle sections, cDNA cloning, expression and 
biochemical analysis of identified proteins to gene knock out techniques (Weisleder, 
2008). (ii) Junctional face membrane purification or heparin agarose chromatography and 
identification of proteins co-eluting with the RyR, combined with Western blotting, Mass 
Spec analysis and peptide sequencing (Divet, 2005). These approaches have been 
relatively successful and at least 5 minor membrane protein components that will be 
described in the next section, have been identified and characterized. 
 
Mitsugumin-29:  
This is a 29 kDa membrane protein related to the synaptophysin-family, originally 
identified in the SR of skeletal muscle and in the endoplasmic reticulum of kidney renal 
tubules (Shimuta, 1998). Analysis of its primary sequence, as well as biochemical and 
ultrastructural evidence suggest that mitsugumin-29 contains 4 transmembrane spanning 
domains and that it is localized in the transverse tubules of mature skeletal muscles where 
it self-associates as hexamers (Shimuta, 1998; Brandt, 2001). Though mitsugumin-29 
does not tightly associate with other proteins, experimental evidence suggests that it can 
functionally interact with the RyR1, whereby it increases RyR1 open probability without 
affecting channel current amplitude (Pan, 2004). Muscles isolated from mitsugumin-29 
KO mice exhibit swollen transverse tubules, vacuolated SR and misaligned triadic 
structures. These ultrastructural changes are accompanied by dysfunctional Ca2+ 
handling; specifically, the intracellular Ca2+ stores of myotubes from mitsugumin-29 KO 
mice deplete more rapidly and refill more slowly after depolarization than myotubes from 
control mice (Pan, 2002). Such alterations lead to “global” functional changes, so that 
muscles from mitsugumin-29 KO mice fatigue more rapidly than their wild type 
counterpart (Nagaraj, 2000). Taken together these results suggest that mitsugumin-29 
functions as a tethering structure, forcing the transverse tubules into a conformation, 
which favors the formation of triadic structures. Lack of integral triads then leads to 
altered Ca2+ handling and defective SOC-dependent Ca2+ influx. 
Junctophilin-1: 
Junctophilins are membrane spanning proteins with a large cytoplasmic region 
containing a 14 amino acid repeat motif (MORN motif) with selective binding affinity for 
the plasma membrane and a carboxy-terminal transmembrane segment spanning the 
ER/SR (Takeshima, 2000). At least three isoforms encoded by distinct genes, exist: 
junctophilin-1 is specifically expressed in skeletal muscle, junctophilin-2 is expressed in 
the heart, in skeletal muscles and in smooth muscles and junctophilin-3 is expressed in 
the brain (Nishi, 2000). In skeletal muscle junctophilin-1 (72 kDa protein) is involved in 
physically linking the transverse tubules to the SR membrane. Protein overlay and 
surface plasmon assays suggest that it achieves this by interacting with phospholipids, 
especially with sphingomyelin and phosphatidylchloine, rather than through protein-
protein interactions (Weisler, 2008). Ablation of junctophilin-1 severely affects muscle 
function leading homozygous KO mice to premature death within 20 h after birth. 
Ultrastructural examination of the skeletal muscles of junctophilin-1 KO mice shows 
morphological abnormalities, including incomplete formation of the junctional 
complexes between transverse tubules and the SR, swollen terminal cisternae and 
reduced numbers of triads. As a consequence muscles develop less contractile force after 
electrical stimulation and show abnormal sensitivity to extracellular Ca2+ (Ito, 2001; 
Komazaki, 2002). 
 
SRP-27/TRIC-A: 
Mitsugumin-33 or TRIC-A (trimeric intracellular cation-selective channel) 
(Yazawa, 2007) also known as SRP-27 (sarcoplasmic reticulum protein of 27 kDa) 
(Bleunven, 2008) is expressed in excitable tissues and is particularly enriched in fast 
twitch skeletal muscles, where its expression level peaks after 2 months of post-natal 
development. Mice lacking TRIC/SRP-27 are viable and display no overt phenotype. 
Double-labeling immunocytochemistry experiments of mouse muscle fibers indicate that 
SRP-27 is localized in the perinuclear endoplasmic reticulum as well as in a SR 
subcompartment, which is adjacent to, but distinct from, that containing the RyR1 and 
SERCA (Bleunven, 2008). Interestingly, SRP-27/TRIC-A could be pulled-down by beads 
coated with maurocalcine and RyR1, but not with maurocalcine alone, raising the 
possibility that SRP-27/TRIC-A is part of the RyR1 macromolecular complex (Bleunven, 
2008). Hydrophobicity plots and biochemical analysis also revealed that TRIC-A/SRP-27 
is an integral ER/SR protein containing up to three membrane spanning domains, whose 
amino-terminus is located in the lumen of the ER/SR and whose carboxy terminus is 
exposed to the cytoplasm. Sequence comparison also predicts the presence of an ion-
conducting pore between the first and second transmembrane domains and cross-linking 
experiments demonstrate that TRIC-A/SRP-27 tends to form homo-oligomers (dimers 
and trimers). Three dimensional reconstruction studies of the native protein suggest that it 
acquires a pyramidal elongated structure, similar to that of bacterial porin channels 
(Yazawa, 2007). Interestingly, reconstitution in lipid bilayers, suggest that TRIC-A/SRP-
27 is a cation channel, with a selectivity of K+ over Na+ (permeability ratio PK/PNa =1.5) 
(Yazawa, 2007). To gain more insight into the function of this channel, Yazawa (2007) 
followed changes in the membrane potential of isolated muscle fibers from control and 
TRIC-A/SRP-27 KO mice. The lack of TRIC-A/SRP-27 reduced the K+ permeability 
accompanying thapsigargin-induced Ca2+ efflux, without affecting Ca2+ permeability, 
suggesting that this protein may act as a monovalent-cation channel.  Such a channel 
could be activated physiologically during RyR1-mediated Ca2+ release to counter-balance 
the charge movement due to efflux of Ca2+ (Somlyo, 1981), which would otherwise leave 
the SR lumen with a negative charge. However, the role of TRIC-A/SRP-27 as a 
monovalent-cation contercurrent channel during Ca2+ release has been challenged by data 
of Gillespie and Fill (Gillespie, 2008) which indicates that the RyR1 channel mediates its 
own potassium countercurrent during SR Ca2+ release. This would obviate the need of an 
additional countercurrent carrier during SR Ca2+ release, leaving the exact functional role 
of TRIC-A/SRP-27 controversial. 
JP-45 
JP-45 is a 45 kDa polypeptide containing a single transmembrane segment, which 
is highly enriched in skeletal muscle junctional face membrane where its expression is 
developmentally regulated, reaching maximal levels during the second month of post-
natal development (Anderson, 2003). Originally JP-45 was identified as a protein weakly 
phosphorylated by cAMP dependent protein kinase and co-eluting with the RyR1 and 
DHPR from a heparin-agarose column (Zorzato, 2000). Surprisingly however, co-
immunoprecipitation experiments revealed that JP-45 is not part of the RyR1 
macromolecular complex, but rather it interacts with calsequestrin via its luminal carboxy 
–terminal domain and with Cav1.1, through its cytoplasmic amino terminus (Anderson, 
2003). Extensive pulldown and co-immunoprecipitation experiments, revealed that JP-45 
binds to different regions on the Cav1.1, namely to its carboxy- terminus and to a region 
within the I-II loop referred to as AID, where the ß1a subunit also binds (Anderson, 
2006). The interaction between Cav1.1 and ß1a is thought to be essential for targeting or 
stabilizing Cav1.1 on the plasma membrane (Flucher, 2002).  
Several approaches have been exploited to unravel the function of JP-45 in skeletal 
muscle: (i) acute over-expression and depletion of JP-45 in differentiated C2C12 
myotubes (Anderson, 2006; Gouadon, 2006) and (ii) chronic depletion in JP-45 knock 
out mice (Delbono, 2007). Interestingly both over-expression and ablation of JP-45 result 
in a decrease of voltage-dependent Ca2+ release. This effect could be due to a decrease of 
functional expression of the Cav1.1 on the transverse tubules (Anderson, 2006; Delbono, 
2007). Alternatively, the effect on Ca2+ release may be linked to alterations of the 
interaction of JP-45 with calsequestrin. Gouadon (2006) showed that low levels of JP-45 
over-expression affect the permeability of the Ca2+ release unit by altering excitation-
contraction coupling transfer function (Gouadon, 2006). Given that the lumenal carboxy–
terminus of JP-45 binds to calsequestrin, it is possible that JP-45 constitutes a key protein 
for a signalling pathway between calsequestrin and Cav1.1. Over-expression of JP-45 
may result in the accumulation of JP-45 molecules which are not associated with 
calsequestrin, and this in turn may send an inhibitory signal to the Cav1.1  
Interestingly the skeletal muscle phenotype of young JP-45 KO mice, is reminiscent of 
that of aged mice. During mouse ageing, the membrane density of the voltage sensor 
(Cav1.1), the SR membrane content of JP-45 and the Ca2+ currents of muscle membranes 
are significantly lower compared to those of young animals (Anderson, 2006; Delbono, 
1995; Gonzales, 2003; Renganathan 1997, 1998).  These data suggest that both Cav1.1 
and JP-45 may be important for the maintenance of muscle strength, and indicate that JP-
45 KO mice may be a useful experimental model to investigate alteration of excitation 
contraction coupling linked to ageing.  
 
Junctate/ humbug 
 Junctate is a 33 kDa protein with a single ER/SR membrane spanning domain, 
expressed in a variety of excitable and non-excitable tissues (Treves, 2000; Dinchuk, 
2000; Hong, 2001). Figure 3A shows how transcripts deriving from the same gene (BAH 
or AßH-J-J locus) located on human chromosome 8q12.1 can give rise to four distinct 
classes of proteins via a complex pattern of alternative splicing. Though the complexity 
of  AßH-J-J locus is more the exception than the rule, it illustrates how important it is to 
precisely establish the number and type of gene products when deciding to create knock 
out animal models of protein(s) encoded by the BAH gene. 
 Figure 3B illustrates schematically how the different polypeptides are assembled to 
yield: (i) junctin, a structural calsequestrin binding protein present in cardiac and skeletal 
muscle SR that forms a quaternary complex with triadin, RyR1 and calsequestrin (Jones, 
1995; Kagari, 1996; Zhang, 1997). (ii) Aspartyl-ß-hydroxylase an enzyme catalyzing 
posttranslational hydroxylation of aspartate and asparagine residues within epidermal 
growth factor-like domains present in receptors and receptor ligands involved in cell 
growth and differentiation, and extracellular matrix molecules (Stenflo, 1989; Gronke 
1989; Monkovic, 1992). (iii) Junctate, a moderate affinity (kD 217 µM), high capacity (21 
moles Ca2+/mole protein) Ca2+ binding protein (Treves, 2000). (iv) Humbug, a truncated 
version of aspartyl-ß-hydroxylase, lacking its catalytic domain, which shares with 
junctate the high capacity moderate affinity Ca2+ binding domain (Dinchuk, 2000; 
Treves, 2000; Hong, 2001). Analysis of the genomic organization of the AßH-J-J locus 
has revealed the presence of two distinct promoters P1 and P2 (Feriotto, 2006) that are 
regulated by specific transcription factors, giving rise to polypeptides with distinct 
amino-termini and tissue distribution. Transcripts starting from exon 1 (green box in 
fig.3A), which is under the control of the P1 promoter, are expressed in most tissues and 
share their NH2 terminus with aspartyl-ß-hydroxylase (Treves, 2000; Dinchuk, 2000; 
Feriotto, 2007). Exon 1a (blue box in fig. 3A) is approximately 8 kb downstream from 
exon 1 and is under the control of the P2 promoter whose induction is controlled by the 
muscle specific transcription factor MEF-2 (Feriotto, 2005). Transcripts starting from this 
exon are expressed in striated muscles and share their NH2 termini with junctin/junctate 
(Treves, 2000; Dinchuk, 2000). Exon 2 encodes the transmembrane domain (yellow box 
in fig.3A) and together with exon 3, is shared by all family members deriving from the 
AßH-J-J locus. The carboxy-terminal portion of the proteins depends on which exons are 
transcribed: junctin results from transcription of exons 4a and 5a, while all other products 
are generated via transcription of exons 4-24 and result in a variety of products of 
different sizes. The longer transcripts give rise to the enzyme aspartyl-ß-hydroxylase with 
an apparent molecular mass of approximately 120 kDa. The shorter transcripts generate 
proteins with molecular masses ranging from 40 to 53 kDa which share the acidic Ca2+ 
binding domain (Treves, 2000; Dinchuk, 2000; Hong, 2001). Heart  expresses junctin and 
junctate, as well as humbug and aspartyl-ß-hydroxylase (Treves, 2000; Dinchuk, 2000; 
Hong, 2001). Interestingly, humbug is also highly expressed in a variety of invasive 
human tumors and its level of expression has been suggested to be useful as a prognostic 
marker for cancer progression (Ince, 2000; Palumbo, 2002; Maeda, 2004; Xian, 2006; 
Wang, 2007; Lee, 2008).  
 In the rest of this section only the functional properties of junctate will be 
discussed, and the reader is referred to other articles describing the function of aspartyl-ß-
hydroxylase and junctin (Gronke, 1989; Wang, 2007; Jones, 1995; Kagari, 1996; Zhang, 
1997). Because of its calcium binding properties, a number of approaches were 
undertaken to define the potential role of junctate in Ca2+ homeostasis: (i) acute over-
expression and depletion junctate from cultured cells (Treves, 2000; Treves, 2004) and 
(ii) chronic over-expression of junctate in skeletal muscles (Divet, 2007) and heart 
(Hong, 2008). Acute over-expression of junctate in COS-7 and HEK293 cells is 
accompanied by significant functional and structural changes of the ER membrane. 
Specifically, in HEK cells over-expressing TRPC3 channels (HEKT3) over-expression of 
junctate induces extensive proliferation of the ER resulting in significantly larger and 
more frequent couplings between the ER and the plasma membrane (Treves, 2004). The 
induction of ER plasma membrane couplings by junctate is in agreement with co-
immunoprecipitation data showing that junctate forms a supramolecular complex with 
InsP3R and TRPC channels.  These structural changes are paralleled by alterations of 
Ca2+ homeostasis, specifically by increased peak Ca2+ release and store-depletion 
activated Ca2+ influx; on the other hand, knocking down junctate results in diminished 
agonist induced peak [Ca2+]i transients and store depletion activated Ca2+ influx (Treves, 
2000, 2004). The increase of store depletion-activated Ca2+ influx is mediated by the 
short cytoplasmic NH2-terminal domain of the protein, while the luminal carboxy-
terminus Ca2+binding domain of junctate (and thus also of humbug) increases the Ca2+ 
content of ER/SR stores and affects calcium transients evoked by SERCA inhibitors.   
 As to the effect of chronic over-expression of junctate, some discrepancies have 
arisen from the transgenic mouse models. Over-expression in skeletal muscles does not 
lead to an overt phenotype but is accompanied by a small increase in Ca2+ loading and 
Ca2+ storage of the SR resulting in a significant increase in RyR1 mediated Ca2+ release 
and an increased Ca2+ influx following depletion of intracellular Ca2+ stores (Divet, 
2007). These changes were attributed to the over-expression of junctate’s Ca2+ binding 
sites since the expression levels of other SR Ca2+ handling proteins such as SERCA, 
calsequestrin or sarcalumenin were not changed. Interestingly, the increased Ca2+ cycling 
across the SR membrane was accompanied by an adaptive increase in the number of 
mitochondria in fast fibres of EDL (but not soleus) muscles, which was not due to fast-to 
slow fibre type transition (Divet, 2007). Junctate over-expression in the heart on the other 
hand, leads to severe cardiac hypertrophy, bradycardia and arrythmias as well alterations 
in the expression level of the SR proteins SERCA2, calsequestrin-2 and calreticulin. This 
decreased SR content of Ca2+ handling proteins is accompanied by an up-regulation of the 
Na+/Ca2+ exchanger and plasmalemma calcium pump, two component of the cardiac 
sarcolemma involved in extrusion of Ca2+ from the cytoplasm. The decrease of the major 
calcium binding proteins of cardiac SR is paralleled by a decrease in caffeine induced 
Ca2+ release indicating a lower cardiac Ca2+ SR loading. At the moment the reasons for 
these apparent opposite effects of junctate over-expression in the heart and in skeletal 
muscle have not yet been elucidated.  
   
Conclusions 
 The past three decades have seen major advancements in our understanding the role 
of skeletal muscle SR proteins in excitation-contraction coupling. The use of genetically 
modified animal models has also taught us that few of these proteins, namely the 
ryanodine receptor, Cav1.1 and junctophyllin, are essential for EC coupling. On the other 
hand, the minor protein components seem to be important for the regulation of the EC 
coupling machinery. Mouse and cellular models have also shown that acute and/or 
chronic over-expression/depletion of a variety of minor components do not result in lethal 
phenotypes and/or in severe damage of to the EC coupling machinery, suggesting that its 
fine regulation is provided by functionally redundant minor components. The 
comprehension of EC coupling and its involvement in the pathophysiology of 
neuromuscular disorders awaits the identification and functional characterisation of the 
complete array of proteins of the transverse tubule and junctional face membrane 
compartments. 
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FIGURE LEGENDS: 
Figure 1: Schematic representation of the protein components of skeletal muscle 
sarcoplasmic reticulum. 
 
Figure 2: Coomassie Brilliant Blue stained gradient (5-15%) SDS PAGE of protein 
components present in the longitudinal sarcoplasmic reticulum (LSR), in terminal 
cisternae (TC) and in the junctional face membrane (JFM) fractions obtained from 
rabbit SR. (reproduced from figure 2, Zorzato 1986). 
 
Figure 3: Genomic organization, splicing pattern and main protein products 
deriving from of the A-ß-J-J locus. Panel A: (reproduced from figure 4, Dinchunk, 
2000). Coloured boxes represent different exons. Products deriving from exon 1 (green 
box) give rise to ß-aspartyl-hydroxylase/humbug; products deriving from exon 1b (light 
blue) give rise to junctin/junctate. Yellow box encodes the transmembrane domain. Panel 
B: schematic representation of the 4 main proteins (junctin, junctate, aspartyl-ß-
hydroxylase and humbug) derived by assembling the different exons (colors of the 
protein domains match those of the exons from which they are derived). 
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